强心剂市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00029971
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

强心剂市场预计在 2023 年至 2031 年期间的复合年增长率为 21.4%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

该报告按药物类型(毛地黄糖苷、磷酸二酯酶抑制剂、心脏保护剂、拟交感神经药等)、应用(心脏外科手术、心房颤动、心力衰竭、肺动脉高压等)、给药途径(口服和肠外给药)、剂型(药片、溶液等)、分销渠道(医院药房、零售药房和网上药房)和地域(北美、欧洲、亚太地区、中东和非洲以及南美和中美洲)对 OTC 消费者保健市场进行细分。全球分析进一步细分为区域和主要国家。该报告提供了上述分析和细分的美元价值。

报告目的

Insight Partners 发布的《强心剂市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

强心剂市场细分

 

药物类型

  • 洋地黄苷
  • 磷酸二酯酶抑制剂
  • 心脏保护剂
  • 拟交感神经药
  • 其他的

应用

  • 心脏外科手术
  • 心房颤动
  • 心脏衰竭
  • 肺动脉高压
  • 其他的

给药途径

  • 口服和肠外

剂型

  • 药片
  • 解决方案
  • 其他的

剂型

  • 药片
  • 解决方案
  • 其他的

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

强心剂市场:战略洞察

Cardiotonic Agents market Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

强心剂市场增长动力

  • 心血管疾病发病率不断上升:心血管疾病 (CVD) 的发病率在全球范围内不断上升,预计到 2030 年,北美将有超过 650 万心力衰竭患者。患者人数的不断增加推动了对强心药等有效治疗方案的需求。
  • 人口老龄化:老年人更容易患心脏相关疾病,这进一步增加了强心剂治疗的必要性。随着预期寿命的增加,与年龄相关的心血管问题也越来越普遍,从而推动了市场扩张。这一因素在最近一段时间内推动了整体市场的增长,预计在预测期内将继续保持类似的趋势。
  • 医疗保健投资不断增加:北美等地区医疗保健支出的增加促进了先进强心剂疗法的开发和普及。医疗保健基础设施的改善使人们更容易获得这些药物,从而推动了市场扩张。这一因素在近期推动了整体市场的增长,预计在预测期内将继续保持类似的趋势。

强心剂市场未来趋势

  • 政府支持:强心剂市场也得到了许多政府项目的支持,这些项目利用资金和公共卫生活动来改善心血管健康。这些努力通常包括资助研究和提高心脏健康意识的活动。
  • 患者教育:患者和医护人员对心血管疾病和强心药物优势的认识不断提高,推动了需求。教育活动有助于让利益相关者了解各种药物在心脏病管理中的价值。
  • 医学界倡导:由于医学界越来越关注强心药在治疗心力衰竭和其他心血管疾病方面的优势,强心药在临床实践中越来越被广泛接受和使用。由于 COVID-19 疫情导致康复患者中心血管问题报告增多,因此作为 COVID 后护理方案的一部分,强心药的需求量也越来越大。随着医疗保健系统适应疫情对心脏健康的长期影响,预计这一趋势将持续下去。

强心剂市场机会

  • 个性化医疗:医生可以通过基因检测找到与心力衰竭和其他心血管疾病相关的特定基因标记。这使得制定个性化治疗方案成为可能,从而最大限度地利用强心药,提高其疗效并降低其副作用。由于个性化治疗更有可能产生良好的效果,因此对适合特定患者需求的强心药的需求更大。
  • 增强药物选择:临床医生可以通过了解患者对特定心血管疾病的遗传易感性来选择最佳的强心药物。基因检测是指导治疗决策的有用工具,因为例如,具有特定基因变异的人可能对各种药物反应更好。
  • 预测性洞察:患者发生心力衰竭或对常规疗法反应不佳的风险可以通过基因检测推断出来。这种预测能力使得早期使用强心药物进行干预成为可能,这可能会改善患者的治疗效果和生活质量。这一因素在近期推动了整体市场的增长,预计在预测期内将继续保持类似的趋势。

 

强心剂市场 市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响强心剂市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的强心剂市场细分和地理位置。

Cardiotonic Agents market Market
  • 获取强心剂市场的区域特定数据

强心剂市场市场报告范围

报告属性细节
2024 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2024 - 2031)21.4%
史料2021-2023
预测期2025-2031
涵盖的领域按药物类型
  • 洋地黄苷
  • 磷酸二酯酶抑制剂
  • 心脏保护剂
  • 拟交感神经药
  • 其他的
按应用
  • 心脏外科手术
  • 心房颤动
  • 心脏衰竭
  • 肺动脉高压
  • 其他的
按给药途径
  • 口服和肠外
按剂型
  • 药片
  • 解决方案
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • Amneal 制药有限公司
  • 辉瑞公司
  • Hikma Pharmaceuticals PLC
  • 费森尤斯卡比
  • Midas Pharma GmbH
  • 赛诺菲
  • 阿拉宾多制药有限公司
  • SimSon Pharma 有限公司。

 

强心剂市场市场参与者密度:了解其对业务动态的影响

强心剂市场正在快速增长,这得益于最终用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在强心剂市场运营的主要公司有:

  1.  
  2. Amneal 制药有限公司
  3. 辉瑞公司
  4. Hikma Pharmaceuticals PLC
  5. 费森尤斯卡比

免责声明上面列出的公司没有按照任何特定顺序排列。


Cardiotonic Agents market Market

 

  • 了解强心剂市场的主要参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了强心剂市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,强心剂市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
cardiotonic-agents-market-report-deliverables-img1
cardiotonic-agents-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


Which country held the second largest share in Europe in 2023?

In Europe, the UK held the second largest share in 2023.

Which region is expected to register highest growth during the forecast period?

Asia pacific region is expected to witness the highest growth during the forecast period

Which region held the largest share in 2023?

North America held the largest share in 2023 and is expected to retain its dominance during the forecast period

What is the expected CAGR of the Cardiotonic Agents Market?

The Cardiotonic Agents Market is estimated to witness a CAGR of 21.4% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Amneal Pharmaceuticals LLC
2. Pfizer Inc.
3. Hikma Pharmaceuticals PLC
4. Fresenius Kabi
5. Midas Pharma GmbH
6. Sanofi
7. Aurobindo Pharma Limited
8. SimSon Pharma Limited.
9. Novartis
10. Merck & Co. Inc.

cardiotonic-agents-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.